<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Carter Copeland | Activity</title>
	<link>https://www.catswannabecats.com/members/bearegg7/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/bearegg7/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Carter Copeland.</description>
	<lastBuildDate>Mon, 29 Jun 2026 10:35:48 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">89a76bd4da0d98a28e19226d8d4eff0e</guid>
				<title>Carter Copeland posted an update: For childhood survivors, quality of life was not influenced [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23727/</link>
				<pubDate>Sun, 08 Jun 2025 10:25:54 -0400</pubDate>

									<content:encoded><![CDATA[<p>For childhood survivors, quality of life was not influenced by age (at HSCT or at last visit), time from HSCT, gender, donor, or GVHD. For survivors that no longer were children, only age at last visit impacted financial domain measures, irrespective of gender, donor, or GVHD. The current study confirms the high burden late complications after&hellip;<span class="activity-read-more" id="activity-read-more-23727"><a href="https://www.catswannabecats.com/activity/p/23727/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1d2722e83cc9f4d1a842df3caa301e36</guid>
				<title>Carter Copeland posted an update: 13 years) and the shortest in late maturing girls (3.25 [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19826/</link>
				<pubDate>Thu, 05 Jun 2025 10:17:11 -0400</pubDate>

									<content:encoded><![CDATA[<p>13 years) and the shortest in late maturing girls (3.25 years). Conclusions Despite the transformation and decline in both AM and ASI, the time interval between these two characteristics remained stable. Significant differences in the time interval were found among women stratified by AM. The time interval between AM and ASI was longer in girls&hellip;<span class="activity-read-more" id="activity-read-more-19826"><a href="https://www.catswannabecats.com/activity/p/19826/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">bd91970d9dd18658278dab25d791abc9</guid>
				<title>Carter Copeland posted an update: MiR-20a shows a significant role in the development of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18768/</link>
				<pubDate>Wed, 04 Jun 2025 10:59:45 -0400</pubDate>

									<content:encoded><![CDATA[<p>MiR-20a shows a significant role in the development of various human tumors. However, its specific biological function in non-small-cell lung cancer (NSCLC) is still not clear. qRT-PCR was applied for detecting miR-20a expression. The analysis of cell growth and apoptosis were performed by MTT, xenograft models, Western blot assays. Dual&hellip;<span class="activity-read-more" id="activity-read-more-18768"><a href="https://www.catswannabecats.com/activity/p/18768/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6b75f06f8cb6a3afc1b99d255d4c2873</guid>
				<title>Carter Copeland posted an update: Moreover, the high expression level of SALL4 was detected in [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/17854/</link>
				<pubDate>Tue, 03 Jun 2025 09:22:04 -0400</pubDate>

									<content:encoded><![CDATA[<p>Moreover, the high expression level of SALL4 was detected in RCC samples and serum from patients. It was demonstrated that SALL4 promotes increased viability in RCC cells. Therefore, the present results suggest that SALL4 may be a sensitive and speciﬁc cancer biomarker in ccRCC and pRCC. Furthermore, targeting of SALL4 may improve RCC therapy a&hellip;<span class="activity-read-more" id="activity-read-more-17854"><a href="https://www.catswannabecats.com/activity/p/17854/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7559e0e330300c5308e909d1370aa390</guid>
				<title>Carter Copeland posted an update: 126) and PSQI score (n = 12 patients; p = 0.127). Treatme [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/1913/</link>
				<pubDate>Sat, 31 May 2025 07:39:40 -0400</pubDate>

									<content:encoded><![CDATA[<p>126) and PSQI score (n = 12 patients; p = 0.127). Treatment significantly improved sleep parameters (n = 17 patients) including total sleep time (p = 0.037), sleep latency (p = 0.022), sleep efficiency (p = 0.015), sleep maintenance index (p = 0.005), wake time after sleep onset (p = 0.015), and duration of N3 sleep stage (p = 0.026). Patients wit&hellip;<span class="activity-read-more" id="activity-read-more-1913"><a href="https://www.catswannabecats.com/activity/p/1913/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">da86d3b0bbcff1831b881ae3539c5f8b</guid>
				<title>Carter Copeland became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/1707/</link>
				<pubDate>Sat, 31 May 2025 07:26:37 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>